TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - August 1, 2023 Category: Cancer & Oncology Authors: Rebecca A Dent David W Cescon Thomas Bachelot Kyung Hae Jung Zhi-Ming Shao Shigehira Saji Tiffany A Traina Petra Vukovic Darlington Mapiye Micah J Maxwell Peter Schmid Javier Cort és Source Type: research